Liang; Wei-Ching
Patent Applications and Registrations
Patent applications and USPTO patent grants for Liang; Wei-Ching.The latest application filed is for "anti-b7-h4 antibodies and immunoconjugates".
Company Profile
18.56.68
- Liang; Wei-Ching - Foster City CA
- LIANG; Wei-Ching - South San Francisco CA
- - Foster City CA US
Patent Activity
| Patent | Date |
|---|---|
| Anti-B7-H4 Antibodies and Immunoconjugates App 20220251213 - Leong; Steven R. ; et al. | 2022-08-11 |
| Anti-B7-H4 Antibodies and Immunoconjugates App 20220162318 - Leong; Steven R. ; et al. | 2022-05-26 |
| Anti-mertk Antibodies And Their Methods Of Use App 20220135701 - LIANG; Wei-Ching ; et al. | 2022-05-05 |
| Anti-B7-H4 antibodies and immunoconjugates Grant 11,286,302 - Leong , et al. March 29, 2 | 2022-03-29 |
| Anti-tigit Antibodies And Methods Of Use App 20220064286 - GROGAN; Jane L. ; et al. | 2022-03-03 |
| Anti-B7-H4 antibodies and immunoconjugates Grant 11,230,600 - Leong , et al. January 25, 2 | 2022-01-25 |
| Isoform-selective Anti-tgf-beta Antibodies And Methods Of Use App 20210301005 - LIANG; Wei-Ching ; et al. | 2021-09-30 |
| Anti-tigit Antibodies And Methods Of Use App 20210253693 - GROGAN; Jane L. ; et al. | 2021-08-19 |
| Anti-CLL-1 antibodies and immunoconjugates Grant 11,084,877 - Zheng , et al. August 10, 2 | 2021-08-10 |
| Anti-tigit Antibodies And Methods Of Use App 20210032328 - GROGAN; Jane L. ; et al. | 2021-02-04 |
| Anti-CLL-1 Antibodies and Methods of Use App 20200148774 - Kelley; Robert F. ; et al. | 2020-05-14 |
| Anti-CD33 antibodies and immunoconjugates Grant 10,556,951 - Yu , et al. Feb | 2020-02-11 |
| ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF App 20190375856 - KELLEY; Robert F. ; et al. | 2019-12-12 |
| Anti-CLL-1 antibodies and methods of use Grant 10,501,545 - Kelley , et al. Dec | 2019-12-10 |
| Anti-HtrA1 antibodies and methods of use thereof Grant 10,421,822 - Kelley , et al. Sept | 2019-09-24 |
| Anti-HtrA1 antibodies and methods of use thereof Grant 10,421,821 - Kelley , et al. Sept | 2019-09-24 |
| Anti-cll-1 Antibodies And Immunoconjugates App 20190248903 - ZHENG; Bing ; et al. | 2019-08-15 |
| Anti-B7-H4 Antibodies and Immunoconjugates App 20190241663 - Leong; Steven R. ; et al. | 2019-08-08 |
| Anti-tigit Antibodies And Methods Of Use App 20190119376 - GROGAN; Jane L. ; et al. | 2019-04-25 |
| Anti-CLL-1 antibodies and immunoconjugates Grant 10,266,597 - Zheng , et al. | 2019-04-23 |
| Anti-CLL-1 antibodies and immunoconjugates Grant 10,239,947 - Zheng , et al. | 2019-03-26 |
| Anti-CLL-1 antibodies and immunoconjugates Grant 10,227,412 - Zheng , et al. | 2019-03-12 |
| Anti-b7-h4 Antibodies And Immunoconjugates App 20190062432 - Leong; Steven R. ; et al. | 2019-02-28 |
| ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF App 20190048097 - Kelley; Robert F. ; et al. | 2019-02-14 |
| ANTI-HtrA1 ANTIBODIES AND METHODS OF USE App 20190016826 - Wu; Yan ; et al. | 2019-01-17 |
| Anti-B7-H4 antibodies and immunoconjugates Grant 10,150,813 - Leong , et al. Dec | 2018-12-11 |
| Anti-cd33 Antibodies And Immunoconjugates App 20180312586 - Yu; Shang-Fan ; et al. | 2018-11-01 |
| Anti-B7-H4 antibodies and immunoconjugates Grant 10,059,768 - Leong , et al. August 28, 2 | 2018-08-28 |
| Anti-TIGIT antibodies and methods of use Grant 10,047,158 - Grogan , et al. August 14, 2 | 2018-08-14 |
| Anti-tigit Antibodies And Methods Of Use App 20180186875 - GROGAN; Jane L. ; et al. | 2018-07-05 |
| Method of reducing blood glucose by administering RON agonists Grant 10,005,848 - Egen , et al. June 26, 2 | 2018-06-26 |
| Anti-CD33 antibodies and immunoconjugates Grant 9,951,133 - Yu , et al. April 24, 2 | 2018-04-24 |
| Anti-cll-1 Antibodies And Immunoconjugates App 20180044421 - Zheng; Bing ; et al. | 2018-02-15 |
| Anti-cll-1 Antibodies And Immunoconjugates App 20180044420 - Zheng; Bing ; et al. | 2018-02-15 |
| Anti-cll-1 Antibodies And Immunoconjugates App 20180009894 - Zheng; Bing ; et al. | 2018-01-11 |
| ANTI-HtrA1 ANTIBODIES AND METHODS OF USE App 20170342163 - WU; Yan ; et al. | 2017-11-30 |
| Anti-CLL-1 antibodies and immunoconjugates Grant 9,751,946 - Zheng , et al. September 5, 2 | 2017-09-05 |
| Anti-b7-h4 Antibodies And Immunoconjugates App 20170239366 - LEONG; Steven R. ; et al. | 2017-08-24 |
| Anti-HtrA1 antibodies and methods of use Grant 9,738,727 - Wu , et al. August 22, 2 | 2017-08-22 |
| Anti-TAT226 antibodies and immunoconjugates Grant 9,675,707 - Liang , et al. June 13, 2 | 2017-06-13 |
| ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF App 20170145113 - KELLEY; Robert F. ; et al. | 2017-05-25 |
| Anti-tigit Antibodies And Methods Of Use App 20170088613 - GROGAN; Jane L. ; et al. | 2017-03-30 |
| Anti-vegf Antibodies App 20170073405 - FUH; Germaine ; et al. | 2017-03-16 |
| Anti-B7-H4 antibodies and immunoconjugates Grant 9,562,099 - Leong , et al. February 7, 2 | 2017-02-07 |
| Anti-cd33 Antibodies And Immunoconjugates App 20170002074 - Yu; Shang-Fan ; et al. | 2017-01-05 |
| Anti-cll-1 Antibodies And Methods Of Use App 20160368994 - Kelley; Robert F. ; et al. | 2016-12-22 |
| Anti-b7-h4 Antibodies And Immunoconjugates App 20160159910 - Leong; Steven R. ; et al. | 2016-06-09 |
| Anti-VEGF antibodies Grant 9,353,177 - Fuh , et al. May 31, 2 | 2016-05-31 |
| Anti-lgr5 Antibodies And Immunoconjugates App 20160102146 - Hongo; Jo-Anne ; et al. | 2016-04-14 |
| Anti-cll-1 Antibodies And Immunoconjugates App 20160075787 - Zheng; Bing ; et al. | 2016-03-17 |
| Antibodies Grant 9,284,376 - Liang , et al. March 15, 2 | 2016-03-15 |
| Ron Compositions And Methods Of Use Thereof App 20160032013 - EGEN; JACKSON G. ; et al. | 2016-02-04 |
| Anti-b7-h4 Antibodies And Immunoconjugates App 20160017040 - Leong; Steven R. ; et al. | 2016-01-21 |
| Anti-tat226 Antibodies And Immunoconjugates App 20150366989 - LIANG; Wei-Ching ; et al. | 2015-12-24 |
| Anti-LGR5 antibodies and immunoconjugates Grant 9,175,089 - Hongo , et al. November 3, 2 | 2015-11-03 |
| Anti-vegf Antibodies App 20150232549 - FUH; Germaine ; et al. | 2015-08-20 |
| Anti-TAT226 antibodies and immunoconjugates Grant 9,109,035 - Liang , et al. August 18, 2 | 2015-08-18 |
| Novel Anti- Alpha5 Beta1 Antibodies And Uses Thereof App 20150203581 - LIANG; Wei-Ching ; et al. | 2015-07-23 |
| Anti-vegf Antibodies App 20150175689 - FUH; Germaine ; et al. | 2015-06-25 |
| Anti-VEGF antibodies Grant 9,018,357 - Fuh , et al. April 28, 2 | 2015-04-28 |
| Anti-VEGF antibodies Grant 8,975,381 - Fuh , et al. March 10, 2 | 2015-03-10 |
| Anti-CD22 antibodies and immunoconjugates and methods of use Grant 8,968,741 - Ebens , et al. March 3, 2 | 2015-03-03 |
| Anti-.alpha.5.beta.1 antibodies and uses thereof Grant 8,962,275 - Liang , et al. February 24, 2 | 2015-02-24 |
| Inhibition of tumor metastasis by anti-neuropilin 2 antibodies Grant 8,920,805 - Wu , et al. December 30, 2 | 2014-12-30 |
| Inhibition of tumor metastasis by anti-neuropilin 2 antibodies Grant 08920805 - | 2014-12-30 |
| Anti-Bv8 Antibodies and Uses Thereof App 20140377860 - Wu; Xiumin ; et al. | 2014-12-25 |
| Anti-b7-h4 Antibodies And Immunoconjugates App 20140322129 - Leong; Steven R. ; et al. | 2014-10-30 |
| Antibodies Grant 8,840,887 - Liang , et al. September 23, 2 | 2014-09-23 |
| Inhibition Of Tumor Metastasis App 20140234312 - Wu; Yan ; et al. | 2014-08-21 |
| Anti-BV8 antibodies and uses thereof Grant 8,771,685 - Wu , et al. July 8, 2 | 2014-07-08 |
| Anti-CD22 Antibodies and Immunoconjugates and Methods of Use App 20140127197 - Ebens; Allen J. ; et al. | 2014-05-08 |
| Binding polypeptides with diversified and consensus VH/VL hypervariable sequences Grant 8,679,490 - Dennis , et al. March 25, 2 | 2014-03-25 |
| Inhibition of tumor metastasis by anti neuropilin 2 antibodies Grant 8,648,173 - Wu , et al. February 11, 2 | 2014-02-11 |
| Anti-lgr5 Antibodies And Immunoconjugates App 20130336885 - Hongo; Jo-Anne ; et al. | 2013-12-19 |
| Anti-vegf Antibodies App 20130315918 - FUH; GERMAINE ; et al. | 2013-11-28 |
| Anti-vegf Antibodies App 20130266581 - FUH; Germaine ; et al. | 2013-10-10 |
| Antibodies and immunoconjugates and uses therefor Grant 8,524,865 - Ebens, Jr. , et al. September 3, 2 | 2013-09-03 |
| Anti-VEGF antibodies Grant 8,512,699 - Fuh , et al. August 20, 2 | 2013-08-20 |
| Anti-VEGF antibodies Grant 8,492,527 - Fuh , et al. July 23, 2 | 2013-07-23 |
| Antibodies And Immunoconjugates And Uses Therefor App 20130171170 - EBENS, JR.; ALLEN J. ; et al. | 2013-07-04 |
| Anti-tat226 Antibodies And Immunoconjugates App 20130156693 - Liang; Wei-Ching ; et al. | 2013-06-20 |
| ANTI-HtrA1 ANTIBODIES AND METHODS OF USE App 20130129743 - WU; Yan ; et al. | 2013-05-23 |
| Novel Anti- Alpha5beta1 Antibodies And Uses Thereof App 20130095096 - Liang; Wei-Ching ; et al. | 2013-04-18 |
| Anti-CD22 antibodies and immunoconjugates and methods of use Grant 8,394,607 - Ebens, Jr. , et al. March 12, 2 | 2013-03-12 |
| Anti-CD22 Antibodies And Immunoconjugates and Methods of Use App 20120329094 - Ebens, JR.; Allen J. ; et al. | 2012-12-27 |
| Anti-vegf Antibodies App 20120322982 - Fuh; Germaine ; et al. | 2012-12-20 |
| Antibodies and immunoconjugates and uses therefor Grant 8,226,945 - Ebens, Jr. , et al. July 24, 2 | 2012-07-24 |
| Novel Antibodies App 20120156129 - Liang; Wei-Ching ; et al. | 2012-06-21 |
| Novel Antibodies App 20120148572 - Liang; Wei-Ching ; et al. | 2012-06-14 |
| Anti-TAT226 antibodies and immunoconjugates Grant 8,183,347 - Liang , et al. May 22, 2 | 2012-05-22 |
| Anti-tat226 Antibodies And Immunoconjugates App 20120100159 - Liang; Wei-Ching ; et al. | 2012-04-26 |
| Anti- .alpha.5 .beta.1 antibodies and uses thereof Grant 8,124,740 - Liang , et al. February 28, 2 | 2012-02-28 |
| Anti-VEGF antibodies Grant 8,101,177 - Fuh , et al. January 24, 2 | 2012-01-24 |
| Anti-bv8 Antibodies And Uses Thereof App 20120014941 - Wu; Xiumin ; et al. | 2012-01-19 |
| Anti-VEGF antibodies Grant 8,092,797 - Fuh , et al. January 10, 2 | 2012-01-10 |
| Antibodies Grant 7,973,138 - Liang , et al. July 5, 2 | 2011-07-05 |
| Antibodies And Immunoconjugates And Uses Therefor App 20110142859 - EBENS, JR.; ALLEN J. ; et al. | 2011-06-16 |
| Anti-vegf Antibodies App 20110020346 - Fuh; Germaine ; et al. | 2011-01-27 |
| Anti-vegf Antibodies App 20110014198 - Fuh; Germaine ; et al. | 2011-01-20 |
| NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF App 20100260782 - Liang; Wei-Ching ; et al. | 2010-10-14 |
| Anti-VEGF antibodies Grant 7,811,785 - Fuh , et al. October 12, 2 | 2010-10-12 |
| Anti-vegf Antibodies App 20100189719 - Fuh; Germaine ; et al. | 2010-07-29 |
| Anti-VEGF antibodies Grant 7,758,859 - Fuh , et al. July 20, 2 | 2010-07-20 |
| Inhibition Of Tumor Metastasis By Anti Neuropilin 2 Antibodies App 20100172921 - Wu; Yan ; et al. | 2010-07-08 |
| Anti-VEGF antibodies Grant 7,691,977 - Fuh , et al. April 6, 2 | 2010-04-06 |
| Novel Antibodies App 20090098112 - Liang; Wei-Ching ; et al. | 2009-04-16 |
| Antibodies And Immunoconjugates And Uses Therefor App 20080050310 - Ebens; Allen J. JR. ; et al. | 2008-02-28 |
| Binding Polypeptides With Diversified And Consensus Vh/vl Hypervariable Sequences App 20070160598 - Dennis; Mark S. ; et al. | 2007-07-12 |
| Anti-VEGF antibodies App 20070141065 - Fuh; Germaine ; et al. | 2007-06-21 |
| Anti-VEGF antibodies App 20070020267 - Fuh; Germaine ; et al. | 2007-01-25 |
| Anti-VEGF antibodies App 20060280747 - Fuh; Germaine ; et al. | 2006-12-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 